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In vivo imaging of tissue/vasculature
oxygen saturation levels is of prime
interest in many clinical applications.
To this end, the feasibility of combin-
ing two distinct and complementary
imaging modalities is investigated:
optoacoustics (OA) and near-infrared
optical tomography (NIROT), both
operating noninvasively in reflection
mode. Experiments were conducted on two optically heterogeneous phantoms
mimicking tissue before and after the occurrence of a perturbation. OA imaging
was used to resolve submillimetric vessel-like optical absorbers at depths up to
25 mm, but with a spectral distortion in the OA signals. NIROT measurements
were utilized to image perturbations in the background and to estimate the light flu-
ence inside the phantoms at the wavelength pair (760 nm, 830 nm). This enabled
the spectral correction of the vessel-like absorbers' OA signals: the error in the
ratio of the absorption coefficient at 830 nm to that at 760 nm was reduced from
60%-150% to 10%-20%. The results suggest that oxygen saturation (SO2) levels in
arteries can be determined with <10% error and furthermore, that relative changes
in vessels' SO2 can be monitored with even better accuracy. The outcome relies on
a proper identification of the OA signals emanating from the studied vessels.
KEYWORDS
blood oxygen saturation, fluence compensation, multimodal imaging, near-
infrared optical tomography, optoacoustic signal quantification, quantitative
optoacoustic imaging, spectral correction
1 | INTRODUCTION
The assessment of tissue and vasculature oxygenation is of par-
amount importance, not only for a better understanding and
profiling of tissues with healthy physiology, but also for a more
effective diagnosis of numerous pathologies through imaging
hypoxia, hyperoxia or anoxia [1]. The essential criteria for a
reliable mapping of oxygenation in vivo include “noninvasive-
ness, adequate spatial and temporal resolution, ability to quan-
tify oxygenation levels, low radiation exposure, good safety
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fulfill these requirements with current imaging modalities
[2–5], optoacoustics (OA), however, has the potential to pro-
vide quantitative estimates of blood oxygenation in the (micro-)
vasculature. The OA signals recorded are proportional to the
absorbed energy density, which can be assumed to be equal to
the product of the optical absorption coefficient of the blood
inside the vessels and the light fluence at the position of these
vessels [6]. By applying an appropriate spectral analysis, that
is, by determining the fluence in the OA images acquired with
different illumination wavelengths, it is possible to retrieve the
shape of the blood's absorption spectrum and, subsequently, the
absolute hemoglobin oxygen saturation (SO2) values inside
these vessels [7]. Accurately estimating the tissue's optical
properties and the fluence is a complex task [8], which could,
for example, be solved by using exogenous markers [9, 10] or
additional modalities [11, 12].
A target application is the early detection of cerebral ische-
mia in preterm infants [13, 14]. Cerebral ischemia is a key initi-
ating factor for white matter injury [13], which has become the
dominant pathology in the premature brain [15] and is a major
reason for long-term neurodevelopmental impairments [15–17].
Reconstructing the optical properties of the infant brain by
means of near-infrared optical tomography (NIROT) has been
investigated, based on the technical progress achieved in near-
infrared spectroscopy (NIRS) [18–25]. This article examines
the feasibility of employing NIROT to estimate the light flu-
ence at the positions of vessels imaged by OA. Using the detec-
tion of ischemia as a blueprint and following on from the work
in refs. [12, 26–29], we designed a hybrid OA/NIROT imaging
system and conducted experiments on two phantoms represent-
ing simplified models of the infant brain. Both phantoms are
composed of dye-filled, submillimetric tubes embedded in a
scattering background, which mimic part of the vasculature
inside the white matter. One phantom also contains larger opti-
cal absorbers, designed to simulate a perturbation in the white
matter (such as those caused by hemorrhages), changing the
local fluence distribution and thereby provoking an alteration
of the OA signals originating from the dye-filled tubes. These
two phantoms were used to model an infant brain at two suc-
cessive points in time. Taking exclusively OA images it would
not unambiguously be possible to decide without additional
knowledge whether the alteration of the OA signals is due to
changes in the SO2 level inside the vessels or due to the pertur-
bation in the white matter. Our study demonstrates the advan-
tage of combining OA with NIROT in, first, solving this
ambiguity, and second, retrieving the ratio of the dye's absorp-
tion coefficients between the wavelength pair (λ1 = 760 nm,
λ2 = 830 nm), with and without the simulated perturbation.
2 | SPECTRAL CORRECTION OF 2D OA
IMAGES BY MEANS OF NIROT: THEORY
Figure 1 illustrates the geometry of the proposed combined
OA/NIROT probe placed on an infant head: the fibers used
for NIROT measurements are arranged on a ring-shaped
holder [30], in the center of which the OA apparatus (ultra-
sound [US] transducer and an illumination module) is
placed. This combined probe is positioned such that the US
transducer is aligned with the acoustically transparent fonta-
nelle [31, 32]. We model the tissue under investigation as a
volume V, in which we distinguish a finite number of blood
vessels, which are imaged by means of OA. To align with a
pixelated OA image, we discretize V into a Cartesian grid of
finite size and given resolution. To each voxel, or position
r = (x, y, z), in the volume is assigned an absorption coeffi-
cient μa,λ(r) and a reduced scattering coefficient μ0s,λ rð Þ for
every wavelength λ. We assume that the reduced scattering
coefficient μ0s,λ rð Þ does not significantly change across V,
while heterogeneities in μa,λ(r) can be significant, due to
spatial variations in the concentration of the main chromo-
phore hemoglobin [25]. The aim of this study is to use OA
imaging to retrieve the spectra of the absorption coefficients
μa,λ at the positions of the submillimetric vessel-like
absorbers that cannot be resolved in NIROT reconstructions.
The NIROT reconstructions are used to determine the light
fluence Φλ(r) arising from the OA illumination inside V
which is used for the spectral correction of the OA signals.
2.1 | OA signal generation and 2D spectral correction
In OA measurements, the tissue is illuminated by a laser
source emitting light pulses that are approximated by a Dirac
delta temporal profile. Thermoelastic conversion of light
absorbed inside the tissue leads to the build-up of an excess
pressure pλ(r), which is the product of the quantities μa,λ(r),
Φλ(r) and the Grüneisen parameter Γ(r) (thermoelastic
FIGURE 1 Schematic drawing of the combined OA/NIROT probe placed
on an infant head, representing the volume V under investigation in the
proposed clinical application. The NIROT fibers (1) are placed on a ring-
shaped holder (2) surrounding the fontanelle. The OA apparatus (3),
composed of a US transducer and an illumination module (not shown here),
is in the middle of this ring. The OA imaging plane σOA and a cross-section
of the volume VR reconstructed with NIROT are shown in orange and blue,
respectively
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conversion efficiency). The excess pressure acts as the
source of a broadband transient ultrasound wave field. Spa-
tially and temporally resolved detection of this wave field at
the tissue surface using an array of US sensors allows the
reconstruction of a quantity Sλ(r). Under ideal conditions
Sλ(r) is equal to pλ(r) (ie, no frequency bandwidth limitation,
detection area encompasses the sample). The proposed clini-
cal setup, however, does not fulfill these ideal conditions,
which has a strong influence on Sλ(r): the limited aperture of
linear array probes (typically around 10 mm length for tran-
scranial probes) provides a high directional sensitivity within
a thin two-dimensional (2D) tissue slice (“OA imaging
plane”, σOA), defined by the direction of the line of the array
elements and by the direction of maximum angular sensitiv-
ity. Due to the narrow angular sensitivity perpendicular to
σOA, the OA signal amplitude depends on the angle of opti-
cally absorbing structures relative to the imaging plane [33].
This results in a scaling of the signal amplitude with an a
priori unknown factor G(r). In addition, the limited fre-
quency bandwidth of the US transducer (typically of the
order of 80% of the center frequency, f0) results in a spatially
dependent image point spread function PSF(r
0
, r) that acts
like a bandpass filter for spatial variations of optical absorp-
tion on the length scale of the acoustic wavelength at f0. The
reconstructed image Sλ(r) can therefore be expressed as
Sλ rð Þ/
ð
σOA
G r0ð Þμa,λ r0ð ÞΦλ r0ð ÞPSF r0,rð Þ dr0 ð1Þ
Owing to the dependence of Sλ(r) on the spatial orienta-
tion of the blood vessels and on the band-limited PSF, the
absolute value of Sλ(r) does not allow for a quantitative
reconstruction of μa,λ(r)Φλ(r). However, the SO2 can be
recovered by analyzing the wavelength-dependent variation
of Sλ(r) / μa,λ(r)Φλ(r) [34], provided that Φλ(r) is known.
To enable this analysis, we identify, for each vessel, a sup-
port, which is defined as a set of pixels in which the signal
values Sλ(r) are determined by the optical absorption inside
that vessel. The support can be any set of pixels that simulta-
neously fulfills the following two conditions: (1) all terms in
the product G(r)μa,λ(r)Φλ(r) in Eq. (1) are constant within
the intersection of the vessel's actual cross-section with the
support, and (2) the support area does not interfere with that
of an adjacent vessel.
As the spatial profile of the signal values Sλ which origi-
nate from a vessel does not depend on the wavelength, the
ratio of μa,λΦλ (which approximates the absorbed energy
density within the vessel) at different optical wavelengths λ1
and λ2 can be determined quantitatively from the pixelwise
ratio of Sλ:
ROA¼ Sλ2Sλ1¼
μa,λ2 Φλ2
μa,λ1 Φλ1
: ð2Þ
ROA, which is only meaningful within the support, is
central to our analysis as it leads to the determination of the
ratio of absorption coefficients at the two wavelengths,
Rμa ¼ μa,λ2=μa,λ1 (reflecting the relative concentrations of
oxyhemoglobin [O2Hb] and deoxyhemoglobin [HHb]), and
consequently to the determination of the SO2 value in the
vessel. Although the ratio ROA is determined pixelwise, there
is no one-to-one correspondence between the spatial distri-
bution of the pixels in the support and the size/shape of the
actual vessel cross-section, due to the convolution of pλ(r)
with the PSF (including side lobes and limited view
artifacts).* The pixel values within the support reflect a set
of statistical realizations of ROA originating from the vessel.
The SO2 in a vessel can be evaluated based on a statisti-
cal analysis of ROA over the support, but its determination
requires information on the wavelength-dependent fluence
Φλ at the position of that vessel within the OA imaging
plane. For each pixel in the support, we calculate a spectrally
corrected OA signal ratio ~ROA:
~ROA¼
~Sλ2
~Sλ1
¼ROA
RΦ
¼Rμa , ð3Þ
with ~Sλ¼ Sλ=Φλ the corrected OA signal and RΦ = Φλ2/Φλ1
the pixelwise ratio of fluences at wavelengths λ1 and λ2. The
wavelength-dependent local fluence Φλ, which depends on
the tissue geometry and composition, that is, on the spatial
distribution of optical properties within V [8, 35], cannot be
measured directly, but it can be estimated using NIROT.
2.2 | NIROT and NIRFAST: principle, calibration
and regularization scheme
In NIROT measurements, the tissue volume V is probed with
a given number of light sources and detectors, all of which
are coupled via optical fibers to the tissue's surface. We
work here with “frequency-domain NIROT,” that is, the
light sources are intensity-modulated with a sinusoidal pro-
file. Each combination of a source and a detector fiber
(source-detector pair) leads to the detection of a time-
dependent signal, characterized by a DC intensity, AC
amplitude and phase of the sine wave, which carry comple-
mentary information on the optical properties inside the
probed “banana-shaped” region [36]. The measurements are
used to solve an inverse problem, which, for every wave-
length, reconstructs a pair of optical properties μa,λ,μ
0
s,λ
 
for every voxel of a volume VR [37].
Practical limitations in the number of source-detector
pairs together with the diffusive propagation of light in tis-
sue make the NIROT inverse problem underdetermined and
ill-posed. Regularization reduces the space of possible solu-
tions by favoring spatial distributions of optical properties
that are measurable by the given geometry of source-detector
pairs. These are typically characterized by slow spatial varia-
tions and low spatial resolution. Despite this constraint, in
practical applications NIROT can produce tomographic
images with resolutions in the order of 5 mm [38, 39].
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To solve the NIROT inverse problem, we use NIRFAST,
a software package developed at Dartmouth University [40].
This Matlab-based code solves the light diffusion equation
on a tetrahedral mesh by the finite element (FEM) approach,
and relies on Tikhonov regularization to constrain the space
of solutions. If the measurements at the tissue surface are
denoted by ψM (phase shifts and logarithms of AC amplitude
decays) and the calculated data using the forward solver by
ψC, then the standard Tikhonov minimization function χ2 for
the reconstruction of the optical properties μ (for a chosen
initial guess μ0) is given by
χ2¼ min
μ
XNM
i¼1 δψ ið Þ
2 + γ
XNN
j¼1 μj−μ0
 2n o, ð4Þ
where δψ i¼ψMi −ψCi , NM is the total number of measure-
ments, NN is the number of FEM nodes (the unknowns) and
γ is the Tikhonov regularization parameter. Optical proper-
ties are updated iteratively according to:
δμ¼ JTJ +2γI −1JTδψ , ð5Þ
where I is the identity matrix and J the Jacobian matrix con-
taining derivatives of logarithms of AC amplitude decays
and phase shifts for each source-detector pair with respect to
the optical properties in each node of the mesh. δψ is the
data-model misfit at the current iteration and δμ is the differ-
ence between optical properties at the current iteration and
the previous one. In NIRFAST, the iteration is terminated
when the relative change of updated optical properties is
smaller than a convergence cutoff, which we kept at 2%.
One problem in the reconstruction is the lack of a unique
set of solutions: μa,λ and μ0s,λ have an interchangeable influ-
ence on the simulated data, so that many different configura-
tions of optical properties can explain the recorded
measurements [25]. Here, this effect is partially reduced by
implementing the assumption that spatial variations in μ0s,λ
are much lower than variations in μa,λ, which allows the
choice of a regularization strength, determined empirically,
that is 100 times stronger for μ0s,λ than for μa,λ. In this case,
the choice of the initial guess for μ0s,λ is especially relevant.
The accuracy of the reconstruction depends on careful
pre-calibration of the NIROT system. This could be done
using a reference phantom with known optical properties,
where amplitude factors and phase offsets are determined
[41]. In addition, the mismatch between the discrete FEM
space and the physical reality leads to meshing artifacts in
the reconstructed properties as well as the simulated light
fluence. In the present study, we have opted for a novel
approach (further developing methods described in refs. [41,
42]), to account simultaneously for amplitude factors, phase
offsets and meshing artifacts. Optical properties are recon-
structed based on a newly defined Δψ :
Δψ ¼ ψM−ψM,ref − ψ C−ψ C,ref  ð6Þ
where the differences between measurements taken on the
studied object and those acquired on an optically homoge-
neous reference phantom are considered. ψM is the data mea-
sured on the studied object, ψM,ref is the data measured on
the reference phantom, ψC is the forward simulated data
based on the current guess and ψC,ref is the simulated data of
the reference phantom according to its known optical proper-
ties. This approach serves as a “custom calibration” proce-
dure and does not require a prior determination of amplitude
factors and phase offsets, as they cancel out via subtraction.
Similarly, a noticeable reduction of meshing artifacts can be
achieved if the same mesh is used for both the studied object
and the reference phantom, whose geometry and optical
properties are taken to be similar to those of the studied
object. The choice of the reference phantom additionally
minimizes residual reconstruction artifacts stemming from
imperfect light coupling.
Finally, the reconstructed optical properties are fed into
NIRFAST to perform forward simulations of the light flu-
ence (in the plane defined by the OA imaging plane σOA),
induced by the OA illumination. The spectral correction for
the OA signals originating from the vessels is then carried
out according to Eq. (3): the uncorrected OA signal ratio
ROA is pixelwise divided by the fluence ratio RΦ (the fluence
is resampled from the tetrahedral mesh to a Cartesian grid,
with the finer pixel resolution of the OA image), resulting in
the corrected OA signal ratio ~ROA in the vessel supports.
3 | EXPERIMENTAL TISSUE MODEL
3.1 | Phantom design and geometry
Two cuboid phantoms were built (referred to as phantom
1 and phantom 2), to roughly model the infant brain at two
different points in time, before and after the occurrence of a
perturbation in its optical properties, for example, due to
hemorrhages. The actual shape and structure of the infant
head is not accounted for and the influence of boundaries
(other than at z = 0) on the light propagation is avoided by
choosing appropriately large phantoms. However, we aimed
to use materials that, as far as possible, optically mimic an
infant's brain [43].
Phantom 1 is comprised of an optically homogeneous,
strongly scattering liquid background material. Inside this
background medium, three identical tubes with a μa value
higher than that of the background were inserted to mimic
blood vessels. These vessel-like inclusions were aligned ver-
tically, in parallel to the y-axis, at a depth of z = 15 mm,
z = 20 mm and z = 25 mm, respectively. Phantom 2 is
quasi-identical to phantom 1, with the difference being that
it includes two supplementary optical heterogeneities in the
form of larger cylinders that have μ0s values similar to that of
the background medium, while their μa value at 760 nm is
higher than that of the background. These cylinders are
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intended to model the aforementioned perturbation in the tis-
sue surrounding the vessels. They have a diameter of 6 mm
and a height of 10 mm, and are positioned with their central
axis at (x, y) = (+7.5 mm, −6 mm) and (x, y) = (−7.5 mm,
0 mm), respectively, and with their top surface at z = 5 mm.
Phantoms 1 and 2 were probed with OA to retrieve the
(spectrally distorted) OA signal ratio ROA of the three vessel-
like tubes (signal at 830 nm divided by signal at 760 nm).
NIROT measurements and reconstructions were performed
to determine the light fluences in both phantoms, to subse-
quently calculate the corrected OA signal ratios ~ROA. In the
two phantoms, the background material's optical properties
are such that ROA varies in depth and the difference between
ROA and ~ROA is noticeable for all three tubes. In phantom
2, the positions and absorption coefficients of the cylinders
were chosen to accentuate the spectral distortion already pre-
sent in phantom 1, and to yield an exploitable contrast in the
NIROT reconstructions.
The accuracy of the spectral correction is assessed by
comparing the retrieved corrected OA signal ratios ~ROA to
the reference value Rμa : according to Eq. (3), in the case of a
perfect spectral correction, these ratios should be equal. To
evaluate the accuracy of the fluence distributions determined
with NIROT/NIRFAST used to perform the correction, they
were compared to reference fluence distributions. In phan-
tom 1, the light fluence can be calculated by the light diffu-
sion approximation ΦD(r) for a semi-infinite, homogeneous
medium [44, 45]:
ΦD rð Þ/ z
d3
1−d  3μaμ0s
 1=2 e−d 3μaμ0sð Þ1=2 , ð7Þ
where d is the distance between the OA illumination point
on the phantom's surface and the position r. Phantom
1 served as a reference to (1) demonstrate the performance
attainable with NIROT/NIRFAST, as the reconstructions for
such a volume are expected to yield reliable results without
any a priori knowledge, and to (2) experimentally establish
the efficiency of quantitative OA imaging with our system.
The reference fluence distribution in phantom 2 was calcu-
lated by Monte Carlo simulations† [46–48]. Calculating the
reference fluences for both phantoms was possible by opti-
cally characterizing all individual volume components inde-
pendently at both wavelengths.
3.2 | Phantom preparation and optical properties of its
individual components
The background medium consists of a lipid solution, which
is considered to be a fairly realistic model of biological tis-
sues and is easy to handle and reproduce [49, 50]. It was pre-
pared by diluting 4.5 vol% of a fat emulsion (SMOFlipid
20%, Fresenius Kabi, Switzerland) with de-ionized water
and Naphthol Green (Naphthol Green B for microscopy,
Sigma-Aldrich, Switzerland) to produce a total volume of
7000 mL, with a fat concentration of 0.9 vol% and a dye
concentration of 1.75 μg mL−1.
The vessels were implemented with polyethylene tubes
(Smiths Medical, Minneapolis, Minnesota, inner diameter
0.28 mm, wall thickness 0.16 mm), filled with a solution of
Indocyanine Green (ICG) dye (IR-125, Laser Grade, ACROS
Organics, Geel, Belgium). The ICG dye was dissolved in etha-
nol (Ethanol p.a., Sigma-Aldrich, Switzerland) resulting in a
concentration of 5 μg mL−1 to attain a spectrally varying opti-
cal absorption in the same order of magnitude as the absorption
of hemoglobin at 760 and 830 nm [51, 52]. The low dye con-
centration used in this study and the choice of ethanol as the
solvent guaranteed that both fluorescence and bleaching effects
were negligible and did not affect the measured OA signals.
Based on the known absorption coefficients of the ICG
solution, a reference value for the aforementioned Rμa was
calculated for all vessels, by dividing the μa at 830 nm by
the μa at 760 nm: Rμa ¼ 0:31. For the fabrication of the two
absorbing cylinders in phantom 2, transparent silicone
(SILPURAN 2420 A/B, Wacker Chemie AG, Munich, Ger-
many) was colored with ELASTOSIL RAL blue 5022
(Wacker Chemie AG, Munich, Germany).
The optical properties of all phantom components are
summarized in Table 1.
4 | EXPERIMENTAL SETUP, DATA
ACQUISITION AND EVALUATION
PROCEDURES
4.1 | Setup description and importance of intrinsic
co-registration
The measurement setup (see Figure 3) mimics the proposed
clinical system shown in Figure 1, however, there are
TABLE 1 Optical properties of the individual phantom components at 760 nm and 830 nm
Sub-volume Wavelength (nm) μa (mm
−1) μ0s (mm
−1) Rμa
Background medium (fat emulsion) 760
830
0.0066 (1%)
0.0048 (2%)
0.91 (2%)
0.82 (2%)
—
—
Vessels (ICG solution) 760
830
0.22 (3%)
0.068 (3%)
—
—
0.31 (4%)
Cylinders (dyed silicone) 760
830
0.16 (10%)
0.0075 (10%)
0.64 (10%)
0.55 (10%)
—
—
The background medium was characterized with time of flight measurements using the method described in ref. [53], the absorption spectrum of the ICG solution was
determined using a commercial spectrophotometer (PerkinElmer Inc., Waltham, Massachusetts), and the optical properties of the silicone cylinders were measured with
a commercial NIRS device (Imagent, ISS Inc., Champaign, Illinois). Measurement uncertainties are given in brackets.
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noticeable differences with respect to both the probing
geometry and the acquisition procedure. The ring-shaped
NIROT probe is replaced by a linear sensor; however, the
circular geometry is attained de facto, by rotating this sensor.
As for US detection, a large aperture vascular probe is used
instead of a transcranial probe. Both modalities are sequen-
tially operated in reflection geometry. The OA and NIROT
probes are attached to a common probe holder. This ensures
an intrinsic geometric co-registration of two-dimensional
OA images and the NIROT volumetric reconstructions,
which is crucial to performing a pixel-based spectral correc-
tion. The common probe holder was designed such that the
rotation axis of the NIROT probe coincides with the center
axis of the OA probe, along the z-axis.
For the OA imaging system, we employed a diode-pumped
Q-switched Nd:YAG laser with integrated optical parametric
oscillator (Spitlight DPSS OPO, InnoLas Laser GmbH, Krail-
ling, Germany), providing laser pulses with 10 nanoseconds
length at a rate of 100 Hz, in the wavelength range of 650 to
900 nm. The light pulses were coupled into a 1 mm core multi-
mode fiber (Thorlabs, Newton, New Jersey) with a numerical
aperture of n = 0.39. The fiber was inclined by 15 with
respect to the z-axis. The wavelength- and time-dependent laser
pulse energy provided by the OPO system was monitored by
reflecting a small fraction of the light onto a pyroelectric energy
sensor before coupling into the fiber. The recorded average out-
put pulse energy at the fiber tip was ~5 mJ. For OA signal
acquisition, we used a linear array ultrasound probe with f0 = 5
MHz center frequency featuring 128 elements with a total aper-
ture of 38 mm at a Δx = 0.298 mm element pitch (ATL L7-4,
Philips N.V., Netherlands), connected to a research ultrasound
system (V 1-64, Verasonics, Kirkland, Washington). The cen-
ter of the ultrasound probe aperture was positioned at the origin
of the lab coordinate frame and the illumination fiber tip at (x,
y, z) = (0 mm, −18 mm, −1 mm).
NIROT measurements were performed with a commer-
cially available NIRS device (Imagent, ISS Inc., Champaign,
llinois). This device employs photomultiplier tubes as detec-
tors and laser diodes as sources emitting at 760 and 830 nm,
modulated with a frequency of 110 MHz. We created a rigid
fiber holder to ensure a reliable positioning of the fiber tips.
Four illumination fibers were placed along a line at 2, 2.5,
3 and 3.5 cm from a detector fiber (see Figure 3B). These
source-detector distances represent the distances available
within the area to be probed on the infant head.
4.2 | Data acquisition and analysis
4.2.1 | NIROT: measurement protocol, choice of the initial
guess
For the NIROT measurements, we ensured that the source
and detector fiber tips were slightly dipped into the liquid
phantom, to achieve a stable coupling and avoid light piping.
Tomographic data were acquired by rotating the sensor in
30 steps of Δα = 12

, covering 360. This resulted in
30 × 4 = 120 source-detector pairs, that is, measurements
NM, in total.
The sizes of the reconstructed volumes are smaller
(−40 mm ≤ x ≤ 40 mm, −40 mm ≤ y ≤ 40 mm, 0 ≤
z ≤ 40 mm) than the actual dimensions of the phantoms
(see Figure 2), in order to keep the computational burden
within reasonable limits, but still large enough that boundary
effects did not influence the fluence calculated at the posi-
tions of the vessel-like inclusions. The node separation dis-
tance of 0.6 mm was a compromise between the
computational costs and the spatial resolution achievable,
given the number of measurements [54].
A key step during the reconstructions is the choice of the
initial guesses [55, 56]. We opted for an approach that does
not rely on a priori assumptions and that is applicable in a
clinical scenario [41]. For each wavelength, a pair of initial
guesses for μa and μ0s was retrieved by fitting, for each rota-
tion angle α, the recorded data set to the frequency-domain
light diffusion model for a homogeneous, semi-infinite
medium [57], and by averaging the fit results over α. It
should be noted that the choice of the initial guesses strongly
influences the outcome of the reconstructions, since any
deviations of the initial guesses from the true values will not
be corrected in regions where the sensitivity of the probing
source-detector pairs is low. In a final step, the light fluences
were calculated from the reconstructed optical properties for
both wavelengths and both phantoms, by means of
NIRFAST-based forward simulations.
4.2.2 | OA: measurement protocol and signal segmentation
Figure 3A shows a sketch of the position of the phantom rel-
ative to the OA probe, with the embedded vessels aligned
perpendicularly to the imaging plane σOA, so that the linear
transducer array provides maximum sensitivity for the vessel
signals. The surface of the probe aperture was slightly
dipped in the liquid phantom.
Datasets were acquired by averaging over 600 consecu-
tive light pulses. This acquisition was repeated for 10 wave-
lengths, ranging from 750 to 840 nm, with a step size of
10 nm, forming one acquisition sequence. This number of
wavelengths was required for image segmentation and was a
tradeoff between acquisition time and segmentation quality.
In total, we repeated the acquisition sequence for five times.
A frequency-domain algorithm [58, 59] was used to recon-
struct images with a spatial resolution of 149 by 74 μm in
the x- and z-direction, respectively.
In section 2, we identified Sλ as the output of the linear
OA reconstruction algorithm (see Eq. (1)), that is, the
radio-frequency (rf-)mode image. As a result of the limited
bandwidth of the probe, the amplitude in the rf-mode image
oscillates, along z, around zero mean with a period deter-
mined by the center frequency of the ultrasound receiver.
Hence, calculating the OA signal ratio ROA (signal at
830 nm divided by signal at 760 nm) from this rf-mode
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image as indicated in Eq. (2) has a significant disadvantage:
the spatial oscillation leads to zero-crossings where the ratio
ROA is not defined or is highly inaccurate in presence of
noise or tissue motion. To avoid this problem, we redefine
Sλ as being the envelope of the rf-mode image, which is a
purely positive function. Even though calculating the enve-
lope constitutes a nonlinear operation, Eq. (2) is still valid.
An integral part of the quantitative analysis of the OA
signal ratio ROA according to Eqs. (2) and (3) is the
identification/segmentation of the supports corresponding to
the vessels in Sλ. The segmentation was based on the
assumption that the OA signal originating from a vessel is
correlated across different wavelengths, while the back-
ground signal is uncorrelated. For each pixel, spectral corre-
lation was quantified by averaging, over consecutive
wavelength pairs (λi, λi + 1), the product of the analytic sig-
nal at λi with the complex conjugate at λi + 1. The supports
were identified by setting a threshold for the spectral
FIGURE 2 Schematic drawing (not to scale) of phantoms 1 and 2 (A), together with side and top view (B and C). Both phantoms consist of subvolumes
characterized by different absorption and reduced scattering coefficients: the background medium (in gray) and three vessel-mimicking inclusions (in green).
The two optical heterogeneities (in dark blue) model a perturbation in phantom 2 but are absent in phantom 1. As in Figure 1, the OA imaging plane σOA and
the volume VR reconstructed by means of NIROT are shown in orange and blue, respectively
FIGURE 3 A, Schematic drawing (not to scale) of the experimental setup. The OA probe consists of a linear array transducer (1) and an illumination fiber
(2). The NIROT probe features four fibers for illumination (S) and one fiber for detection (D), fixed to a linear fiber holder (3), which is attached to a
rotational stage (4). OA and NIROT probes are sequentially mounted on a common probe holder (5) for an intrinsic registration between the two
modalities. B, Cross-section of the NIROT linear sensor in the x, y-plane, showing illumination (S) and detection (D) fibers. Tomographic data were acquired
by rotating the sensor stepwise around the z-axis by an angle α ranging from 0 to 360
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correlation. To determine this threshold, we had to make a
tradeoff between preserving a statistically meaningful num-
ber of pixels in the supports, while excluding pixels where
the signal is governed by noise. We empirically established
that this is achieved if the support of the vessel at 25 mm
depth contains 25 pixels.
5 | RESULTS
5.1 | Uncorrected OA image ratios: quantifying
spectral distortion
Figure 4A,B show the uncorrected OA signal ratio ROA com-
pared to the reference ratio Rμa for both phantoms averaged
in each case over the five acquisitions. For better visualiza-
tion, the data is shown in a region of interest (ROI) covering
the supports. The cylindrical inclusions in phantom 2, located
outside the ROI, could not be imaged due to the limited
bandwidth of the US probe. Within the supports, the pixel
values quantify the spectral distortion (and in the absence of
any distortion, the OA signal ratio ROA is expected to be
equal to the reference ratio Rμa ). The supports can qualita-
tively be distinguished from the noisy background, but with-
out a clear delineation. The segmented OA signal ratios are
given in Figure 4C,D, for phantoms 1 and 2, respectively.
Figure 4 clearly reveals that the supports have noncircular,
irregular geometries and that their areas exceed the actual
area of the vessel-mimicking tubes, due to the influence of
the PSF. The lower signal-to-noise ratio (SNR) at a depth of
25 mm results in a weaker spectral correlation, and thus, in a
smaller support for the third vessel. It is also apparent that
values of the OA signal ratio are nonuniform across each
support and deviate from the reference. For phantom 1, the
spectral distortion increases with depth, with the OA signal
ratio ranging on average from  1:6×Rμa for the vessel at
15 mm to  1:9×Rμa for that at 25 mm, despite the fact that
in all vessels, the dye concentration and absorption spectrum
is identical. In phantom 2, the distortion is even stronger,
with the OA signal ratio being in the order of 2 ×Rμa to
2:5×Rμa . In an in vivo monitoring scenario where the same
infant brain is probed at two different points in time, it
would be difficult without NIROT to infer whether the dif-
ference in spectral distortion observed between the two
points in time is the result of a change in the vessels' SO2
levels, or that of a perturbation occurring in the surrounding
tissue.
5.2 | NIROT reconstructions of optical properties
The initial guesses for μa and μ0s determined according to the
technique described in section 4.2.1 are given in Table 2, for
both wavelengths and both phantoms. There was no discern-
ible difference between the NIROT measurements (phase
shifts and logarithms of AC amplitude decays) on phantom
1 and those on the homogeneous reference phantom, that is,
as anticipated our NIROT system was not sensitive to the
presence of the three vessels. Under these conditions, the
retrieved initial guesses for phantom 1 are close to the back-
ground material's reference optical properties, with ~1% to
3% inaccuracy at 760 nm and ~7% to 15% inaccuracy at
830 nm. It can be seen that the presence of the additional
cylindrical inclusions in phantom 2 yields different initial
guess values. The sets of initial guesses were included in the
reconstruction algorithm, to determine the absorption and
reduced scattering coefficient for every voxel, for both
wavelengths and both phantoms.
Two-dimensional cross-sections of μa through phantom
1 at 760 nm are given in Figure 5A (along the plane defined
FIGURE 4 Uncorrected OA signal ratio ROA in units of the reference Rμa
for phantom 1 (A) and phantom 2 (B) shown in the selected ROI. The same
data is displayed in (C) for phantom 1 and (D) for phantom 2, after
segmentation of the supports
TABLE 2 Initial guesses of optical properties for phantoms 1 and 2, at
760 and 830 nm
Phantom Wavelength (nm)
Initial guess
for μa (mm
−1)
Initial guess
for μ0s (mm
−1)
1 760 0.0068 (+3%) 0.90 (−1%)
830 0.0055 (+15%) 0.76 (−7%)
2 760 0.0072 (+9%) 1.05 (+15%)
830 0.0057 (+19%) 0.78 (−6%)
The relative deviations (in %) from the reference optical properties of the back-
ground medium (see Table 1) are given in brackets.
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by the OA imaging plane) and Figure 5B (along a plane of
constant depth at z = 8 mm). Black-dashed lines indicate the
positions of the vessels and the ROI. The three vessels are
not visible and the distribution of optical properties appears
to be quasi-uniform across the phantom. The reconstructed
μa differs by <0.5% from the initial guesses and diverges
from the background's reference μa on average by ~3% at
760 nm and ~15% at 830 nm. These results are quite
remarkable, given that no a priori knowledge was employed
in the NIROT reconstructions. The deviations from the refer-
ence values give a measure of the accuracy that can be
expected from NIROT reconstructions with the chosen
experimental setting.
Similarly, Figure 5C,D shows μa in cross-sections through
phantom 2. As in phantom 1, the vessels are not detected, but
the larger cylinders (which have a strong absorption at
760 nm compared to the background) are qualitatively
imaged. Closer examination of Figure 5C,D reveals that the
contrast in the reconstructed μa extends to regions outside the
actual cylinders' locations and that the absolute values of μa
are considerably lower than the cylinders' real absorption
coefficient (the maximum reconstructed μa still underesti-
mates the reference μa of the cylinder by a factor ~5): this
combined effect is a consequence of the ill-posedness and
underdetermination of the reconstruction problem [60].
Across phantom 2, the reconstructed μa values differ, on aver-
age, from the reference values by ~6% at 760 nm. At 830 nm,
the cylindrical inclusions are not visible in the reconstruction
(not shown here), since their optical properties are comparable
to that of the background. At this wavelength, the recon-
structed μa values deviate by about ~15% from the back-
ground's known absorption coefficient. As opposed to the
results obtained in phantom 1, the reconstructed μa values
deviate noticeably from the initial guesses (8% at 760 nm and
4% at 830 nm). Due to the strong regularization implemented
into the reconstruction procedure, μ0s values for both phan-
toms globally differ less than 1% from the initial guess (also
not shown here): the inaccuracy of μ0s is given by that of the
initial guess (<15%, according to Table 2).
From a diagnostic viewpoint, the visibility of the absorb-
ing cylinders in the reconstructions shown in Figure 5C,D
confirms the presence of a perturbation in the tissue. This
provides valuable complementary information to the OA
data given in section 5.1: in vivo, this would suggest that the
changes in the OA signal ratio between the two points in
time represented by phantoms 1 and 2 might be due to this
perturbation and not to actual variations in the blood's SO2.
This hypothesis can be validated by examining the corrected
OA data with and without the presence of the perturbation.
The quality of the correction depends on the estimation of
the light fluence inside the volume, and in the following we
are interested in inspecting the effect of the quantitative
errors in reconstructed optical properties on the fluences
determined for both phantoms.
FIGURE 5 Spatial distributions of the reconstructed μa values at 760 nm along the OA imaging plane for phantom 1 (A) and phantom 2 (C) and in the x, y-
plane at z = 8 mm for phantom 1 (B) and phantom 2 (D). Black-dashed lines: vessel-like tubes and ROI. Blue-dashed lines: absorbing cylindrical inclusions.
White-dashed lines in A and C indicate the planes shown in B and D and vice versa
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5.3 | Fluence ratios obtained with NIRFAST
To validate the performance of NIROT/NIRFAST, we com-
pared the fluence distributions determined by NIROT/NIR-
FAST to calculated reference fluence distributions. In lieu of
comparing the fluence distributions themselves, we com-
pared the respective fluence ratios RNFΦ (the fluence at
830 nm divided by the fluence at 760 nm), since this ratio
directly determines the quality of the spectral correction of
the OA images.
Figure 6A shows the fluence ratio RNFΦ obtained with
NIRFAST for phantom 1, compared to the reference fluence
ratio RDΦ obtained by applying the analytical diffusion
approximation. Very good agreement can be observed: RNFΦ
varies only between 0:88×RDΦ and 0:94×R
D
Φ across the
whole ROI (a perfect agreement would result in RNFΦ being
equal to RDΦ). The analytical diffusion approximation is
known to provide a reliable fluence estimation in phantom
1, and as such the accordance between RNFΦ and R
D
Φ in this
phantom gives a measure of the accuracy to be expected
from NIROT/NIRFAST under favorable conditions.
Figure 6B compares the fluence ratio RDΦ obtained from
the analytical diffusion approximation with the reference flu-
ence ratio RMCΦ for phantom 2, determined with Monte Carlo
simulations. RDΦ is identical to the reference fluence in
Figure 6A (for phantom 1) and was thus determined assum-
ing a homogeneous medium, while RMCΦ takes the absorbing
cylinders into account. The substantial differences between
RDΦ and R
MC
Φ underline that the presence of the cylindrical
inclusions cannot be neglected. By comparing Figure 6B to
Figure 6C (the latter compares RNFΦ with the reference from
Monte Carlo simulations), it becomes apparent that there is a
much better agreement between the fluence distribution pro-
vided by NIRFAST and the reference obtained by Monte
Carlo simulations than there is between the fluence calcu-
lated with the diffusion approximation and the reference
from Monte Carlo simulations. This underlines the
advantage of using NIROT to estimate the fluence distribu-
tion in the presence of a perturbation, over methods that
assume a homogeneity of the background medium. For
phantom 2, RNFΦ ranges from approximately 0:71×R
MC
Φ to
0:92×RMCΦ across the ROI and is thus quantitatively not as
close to the reference as the one for phantom 1, which can
be attributed to the higher degree of complexity involved.
5.4 | Spectrally corrected OA signal ratios: correction
quality and relevance of NIROT
The uncorrected OA signal ratios ROA (see Figure 4) have
shown that signals in all vessel supports are affected by
spectral distortions and that these are stronger in phantom
2 than in phantom 1. NIROT reconstructions and light flu-
ence calculations have revealed that the differences in the
distortions between the phantoms may be explained by the
perturbation in phantom 2. To conclude our results, we cal-
culate the corrected OA signal ratios ~ROA, from the uncor-
rected ratios ROA and the fluence ratios RΦ.
The results after spectral correction for phantom 1 are
shown in Figure 7 by displaying the corrected OA signal
ratio ~ROA (averaged over five acquisitions) in units of the
reference ratio Rμa . In Figure 7A, the correction has been
performed using NIROT/NIRFAST, whereas in Figure 7B,
the correction was undertaken with the fluence distribution
calculated with the analytical diffusion approximation. By
comparing these images with those shown in Figure 4C, the
necessity for spectral correction becomes evident (~ROA
almost equals Rμa ). Comparing Figure 7A and B reveals that
spectral correction for phantom 1 with NIROT is as good as
with the analytical diffusion approximation. To quantify the
FIGURE 6 Phantom 1: Fluence ratio RNFΦ obtained with NIRFAST in units of the reference fluence ratio R
D
Φ, calculated based on the analytical diffusion
approximation (A). Phantom 2: fluence ratio RDΦ obtained with the analytical diffusion approximation (neglecting the cylindrical inclusions) in units of R
MC
Φ
from Monte Carlo simulations (B) and fluence ratio RNFΦ from NIRFAST, also in units of R
MC
Φ (C). All images are confined to the ROI; white circles indicate
actual cross-sections of the vessels
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spectral correction, while accounting for the nonuniformity
within the supports, we plotted histograms of the pixel
values within the supports before (red) and after (green) cor-
rection for all five acquisition sequences and determined the
deviation of the histograms' peaks from the reference. Before
correction, the peak positions of the histograms lie between
1:6×Rμa and 1:9×Rμa for the three vessels, while after cor-
rection the peak positions are between 1:1×Rμa and
1:2×Rμa for the correction with NIROT/NIRFAST and
at≤ 1:05×Rμa for the correction with the analytical diffusion
approximation.
Figure 8A,B shows the results for phantom 2 after spec-
tral correction performed with NIROT/NIRFAST and based
on Monte Carlo simulations. The comparison between
Figure 8A and B reveals that both methods perform equally
well. The peak positions of the histograms showing the cor-
rected OA image ratio ~ROA are at < 1:2×Rμa and
> 0:8×Rμa , respectively.
It is worth stressing how effectively NIROT corrects the
OA signals for all three supports, both in phantom 1 and
phantom 2. NIROT accounts for the spatial and spectral vari-
ations of the light fluence inside the probed volume of phan-
tom 2 despite the uncertainties in the reconstruction of the
cylindrical inclusions' positions and optical properties. In
our assumed in vivo situation, the combined results from
OA and NIROT would clearly assert that the differences
obtained between the two different points in time are not due
to changes in the vessels' SO2, but due to a perturbation in
the surrounding tissue.
6 | INTERPRETATION OF THE SPECTRAL
CORRECTION RESULTS
This study has demonstrated that under favorable conditions
(ie, calibration/probing procedure and choice of initial
guesses), NIROT constitutes a clinically viable modality to
FIGURE 7 OA signal ratio ~ROA for phantom 1 corrected with NIROT/
NIRFAST (A) and corrected based on the analytical diffusion
approximation (B), in units of the reference ratio Rμa , together with
histogrammed pixel values within the supports, before (red) and after
(green) fluence correction. In the subplots showing the histograms, numbers
refer to the vessel index and perfect agreement with the reference is
indicated with a black line
FIGURE 8 OA signal ratio ~ROA for phantom 2 corrected with NIROT/
NIRFAST (A) and corrected based on Monte Carlo simulations (B), in units
of the reference Rμa , together with histogrammed pixel values within the
supports, before (red) and after (green) correction. In the subplots showing
the histograms, numbers refer to the vessel index and perfect agreement
with the reference is indicated with a black line
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complement OA for the spectral correction of vessel signals
in a combined reflection-mode handheld setup. Second, we
have shown its value for understanding temporal variations
of the OA signals, via monitoring of tissue surrounding the
vessels. Furthermore, we have demonstrated that the quanti-
tative evaluation of OA images relies on the identification of
the supports representing individual blood vessels.
6.1 | On the shape/size and the pixelwise
nonuniformity of signals originating from vessels
in 2D OA reconstructions
In OA imaging, the PSF depends not only on the system,
but also on the a priori unknown spatial distribution of
acoustic properties, which causes the variations in size and
shape of the segmented supports corresponding to the differ-
ent vessels imaged in our experiments. These variations,
however, do not pose a problem: rather than the spatial char-
acteristics of the supports, it is the statistics of the pixel
values therein that are of interest for our quantitative analy-
sis. As can be seen in Figure 4, the pixel values within the
supports have a nonuniform distribution although the two
conditions stated in section 2.1 (that have to be fulfilled by
the supports) indicate that the OA signal ratio ROA must be
constant across the supports. A violation of the first condi-
tion seems implausible, as the small size of the vessels and
the low concentration of the absorbing dye used make non-
uniformities in the absorbed energy density within the ves-
sels very unlikely [6]. The second condition is equally
fulfilled, since the individual supports do not overlap. The
pixelwise spectral correction (ie, dividing the OA image
ratio by the 2D light fluence ratio across the full support
area) also cannot be responsible for the nonuniformity.
Indeed, the SD of the fluence ratios RNFΦ across the supports
was <1% for all vessels and both phantoms.
Upon thorough examination of all the data we believe
that the nonuniformity is rather due to motion of the vessels
caused, for example, by convection inside the liquid back-
ground medium or by the repeated flushing of the ICG dye
solution into the vessel-mimicking tubes. Simulations indi-
cated that a displacement of only 50 μm during the acquisi-
tion time would explain the observed nonuniformity. In
agreement with this hypothesis, we obtain random fluctua-
tions of ROA mainly toward the profile tails, so that the SD is
higher at the border of the support. This is illustrated by
Figure 9A, where we show the pixelwise SD of the OA sig-
nal ratio ROA across the five acquisition sequences (carried
out over the course of ~10 minutes) for phantom 1, reflecting
temporal fluctuations in ROA. Restricting the quantitative
analysis to the central parts of the supports reduces the width
of the ROA and ~ROA histograms (see Figure 9B) but keeps
the peak positions of the histograms unchanged. The nonuni-
formity across the supports should, therefore, not be consid-
ered as a source of error. Still, we acknowledge it as being
central and inherent to the analysis of OA signals originating
from blood vessels, as motion might happen in vivo even
more than in a well-controlled phantom experiment.
We propose that given the nonuniformity across the sup-
port, the chosen histogram technique guarantees a robust
quantitative analysis: the peak position intrinsically reflects
ROA values stemming from pixels that are most reliable
within the support.
6.2 | Evaluating the quality and reproducibility
of the OA measurements
Results obtained with phantom 1 can be exploited to deter-
mine the accuracy of the spectral correction achieved with
our OA system. As shown in Figure 7B, we identified an
error of ≤2% for the first two vessels and an error of ≤5%
for the third vessel, based on the peak positions in the histo-
grams of the corrected OA signal ratio ~ROA values. To verify
the reproducibility of these results, we repeated the entirety
of the measurements five times (ie, five times the five acqui-
sition sequences described in section 4.2.2) on phantom
1, which was produced anew for each repetition. The inde-
pendently retrieved corrected OA signal ratios ~ROA (cor-
rected with RDΦ) are on average  1:05×Rμa across the
supports, with a SD of ~4%. Although these results indicate
an excellent, reproducible spectral correction, some sources
of systematic errors limit the accuracy of the outcomes. The
deviation of the corrected OA signal ratio ~ROA from Rμa par-
tially stems from the uncertainties in the optical properties of
the phantom's background material and the ICG absorber
(~2% and ~3%, respectively: see Table 1), which in turn
translate into uncertainties in the reference fluence ratio RDΦ
and the corrected OA signal ratios ~ROA (error in the order of
4%-5%), as well as in the reference ratio Rμa (error approxi-
mately 4%). Moreover, in the course of our experimental
FIGURE 9 A, Pixelwise relative SD σrel of ROA across the five acquisition
sequences for phantom 1. B, Histogrammed pixel values showing
uncorrected OA signal ratios ROA (red) and corrected OA signal ratios ~ROA
(green), both in units of the reference, in the central parts of the supports for
phantom 1, overlaid by the histogram contours from Figure 7A (black lines)
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work, we established that OA measurements can be influ-
enced by spectral and temporal fluctuations in the laser pulse
energy that are not accounted for in the monitoring method
described in section 4.1. Temporal variations in the ratio
between the energy measured at the sample and in the refer-
ence path added an uncertainty of ~1% to 3% to the OA sig-
nal ratio.
6.3 | Investigating the clinical applicability
of our technique
6.3.1 | Calculating exemplary SO2 maps from corrected
OA image ratios: translation of errors
In order to determine the quality of the spectral correction of
the OA images with NIROT, we have compared the uncor-
rected and corrected OA signal ratio, ROA and ~ROA, across
the supports to the reference ratio Rμa , calculated from the
known absorption spectrum of the ICG solution used to
mimic blood. In an in vivo experiment, where actual blood
vessels are to be imaged, the clinically relevant parameter is
the oxygen saturation level SO2 within a vessel, which can
be calculated from the ratio of absorption coefficients
between two wavelengths λ1 and λ2, that is, the corrected
OA ratios ~ROA, according to
SO2¼ ϵ
HHb
λ2 −ϵHHbλ1 ~ROA
ϵHHbλ2 −ϵ
O2Hb
λ2 − ϵHHbλ1 −ϵ
O2Hb
λ1
 
~ROA
: ð8Þ
To understand the clinical significance of the experimen-
tal results, we assumed that the tubes were filled with blood
instead of the ICG dye solution. Based on the absorption
spectrum of blood with an SO2 value of SO
ref
2 ¼ 98% [52],
we generated artificial, spectrally distorted and corrected OA
data, by keeping the same relative errors as the ones
observed in section 5 between uncorrected or corrected OA
signal ratios and the reference. This time, instead of plotting
uncorrected and corrected OA signal ratios in units of the
reference across the supports for both phantoms, we plot the
SO2 values obtained from the artificial OA data (SOsim2 ) in
units of the reference SO2 value (SO
ref
2 Þ. This is shown in
Figure 10, before (A and D) and after correction (B and E).
The uncorrected SO2 values were calculated by replacing in
Eq. (8) the corrected OA signal ratio ~ROA by the uncorrected
ratio ROA. In Figure 10C,F, as in the representation used in
section 5, we plot histograms of the SO2 values across the
supports. A perfect correction would result in SOsim2 values
equal to SOref2 : before correction, the peak positions of the
SOsim2 values are in the range of 1:2× SO
ref
2 to 1:4× SO
ref
2 ;
after spectral correction, the values are at 1:05× SOref2 to
1:1× SOref2 . This indicates that, after correction, absolute
SO2 values can be estimated with <10% error for both phan-
toms. Furthermore, our results suggest that the relative
change in SO2 between two points in time can be measured
with much higher accuracy than the absolute value. This is
seen in Figure 10, as no deviation in peak positions between
C and F is visible after correction.
The error in determining SO2 levels does not only
depend on the quality of the spectral correction but also on
the reference value SOref2 , as the propagation of errors in the
corrected OA signal ratios ~ROA into SO2 varies with SO
ref
2 .
Figure 11 illustrates this dependency for different inaccura-
cies in the spectral correction. Applying the inaccuracies
obtained in our phantom experiments, which correspond to
~ROA values of 1:1×Rμa to 1:2×Rμa , an absolute error of
around 5% to 9% for arterial SO2 levels (SO
ref
2 ~98%), and an
absolute error of around 6% to 12% for venous blood
(SOref2 ~75%) can be expected. Moreover, the error in the
estimation of SO2 levels depends on the selection of wave-
lengths [61]. In this study, the wavelength pair (λ1 = 760 nm,
λ2 = 830 nm) was given by the commercial NIRS/NIROT
apparatus we worked with. In the future, the selection of a
larger set of wavelengths could improve the SO2 accuracy to
potentially meet that achieved by other non-invasive tech-
niques that are currently in clinical use but lack spatially
resolved information [62].
6.3.2 | Further prospects: completing SO2 maps on a larger
scale by using NIROT reconstructions
From a diagnostic standpoint, it is of great interest to
simultaneously visualize the (de)correlations between SO2
levels in the vasculature and the physiological/functional
changes in the surrounding tissue. This is illustrated in
Figure 12, where we have reconstructed a hybrid
OA/NIROT image: here, Figure 10E has been superim-
posed onto a NIROT image displaying the relative changes
in μa at 760 nm (obtained from the reconstructions pre-
sented in Figure 5). Such a hybrid OA/NIROT image not
only displays spatially resolved SO2 levels in the vessels,
but also reveals the occurrence of a perturbation in the
background between the time points matching phantoms
1 and 2.
Considering the fact that a hybrid OA/NIROT imaging
system additionally offers the possibility to use classical
echo ultrasound imaging, this multimodal system will pro-
vide anatomical tissue information as well as quantitative
SO2 levels in single vessels at an imaging depth of 2 to
3 cm. Such an imaging device is of high diagnostic value
not only for the proposed application in neonatology but
also, for example, in oncology.
7 | SUMMARY AND OUTLOOK
In this study, we implemented a hybrid OA/NIROT system
operated in reflection mode to assess to what extent NIROT
can be used to correct spectrally distorted OA signals ema-
nating from vessel-like structures. The setup and experi-
ments were designed and conducted to comply with the
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prerequisites for a reliable in vivo mapping of oxygenation
in the brain of preterm infants. Our results, obtained from
measurements on optically heterogeneous phantoms, indi-
cate that a clinically promising spectral correction is feasible:
in the OA data, the errors in the ratio of the blood-mimicking
dye's absorption coefficient at 830 nm to that at 760 nm
decreased from >100% to <20%, for vessel-like tubes posi-
tioned at depths ≤25 mm. This means that, if we were to
assess SO2 values in arteries, the estimation error could be
reduced from >30% to <10%. This error could potentially
be further reduced by exploiting the full capacity of the
hybrid OA/US/NIROT modality functioning on the basis of
a mutual feedback system, where OA and US images are
used to provide NIROT reconstructions with a priori knowl-
edge [63–66]. Such mutual feedback could also be used to
facilitate the interpretation of the quantitative data delivered
in vivo by OA, NIROT and US. Our phantom experiments
show that NIROT reconstructions could help in corroborat-
ing results obtained with OA, as they offer monitoring of the
background tissue to detect the occurrence of a perturbation
over time. In a similar manner, clinically meaningful SO2
values retrieved with OA could serve as a quality measure of
the NIROT reconstructions.
Moreover, in quantitative OA imaging the proper estima-
tion of the light fluence is often cited as the main challenge,
but we demonstrated that the proper identification and inter-
pretation of the vessel signals within the reconstructed OA
images deserves equal attention. We therefore recommend
the segmentation of the support corresponding to an individ-
ual vessel, as well as an appropriate statistical analysis to
account for the nonuniformity of the pixel values across this
support.
Despite the excellent results obtained in this phantom
study it is still difficult to predict whether this hybrid
FIGURE 10 Simulated SO2 levels (SOsim2 ) are shown in units of the reference SO2 level (SO
ref
2 ) before (A, D) and after (B, E) correction for phantoms 1 and
2, respectively. The histogrammed pixel values are displayed in C and F
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imaging modality will perform as well in vivo where further
optimization strategies tailored to the high complexity and
heterogeneity of the target tissue might be needed [25, 54].
Future steps will include the construction of the prototype
sketched in Figure 1 to examine the applicability of our
multi-modal system for the early detection of cerebral ische-
mia in preterm infants. In particular, effects induced by the
nontrivial geometry of the head or by shadowing due to
densely distributed vessels/capillaries are yet to be further
investigated.
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NOTES
*Note that from a practical viewpoint, grating lobes should not be included
into the support, as they occur at a location “far away” from the vessel and
it will be difficult to establish a correspondence with a specific vessel.
†Monte Carlo simulations were performed with a spatial resolution of
1/6 mm and by generating 1010 photon paths.
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